Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

ClinicalTrials.gov ID: NCT02148796

Public ClinicalTrials.gov record NCT02148796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)

Study identification

NCT ID
NCT02148796
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Arizona
Other
Enrollment
822 participants

Conditions and interventions

Interventions

  • Broncho-Vaxom (BV) Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
6 Months to 18 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2016
Primary completion
Jan 29, 2026
Completion
Jan 29, 2026
Last update posted
Jun 1, 2026

2017 – 2026

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
University of Arizona Tucson Arizona 85724
University of California San Francisco, Benioff Children's Hospital Oakland California 94609
Children's National Health System Washington D.C. District of Columbia 20037
Emory University Atlanta Georgia 30322
Boston Children's Hospital, Harvard University Boston Massachusetts 02115
Washington University St Louis Missouri 63110
Columbia University New York New York 10032
University of North Carolina Chapel Hill North Carolina 27514
Cincinnati Children's Hospital & Medical Center Cincinnati Ohio 45229
University of Wisconsin Madison Wisconsin 53792-4108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02148796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02148796 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →